The important role of CCL2 in TAM accumulation is supported by the evidences that the levels of tumor-derived CCL2 is correlated with the number of TAMs in several types of tumor, including pancreatic, breast and ovarian cancer [74, 75]. The gene discussed is CCL2; the disease is ovarian carcinoma.